Levocabastine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C26H29FN2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 124XMA6YEI, chemically known as 4-piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (3s,4r)- but more generally known as levocabastine hydrochloride, which bears US NIH Compound Identifier 54384. European Medicines Agency schedules Levocabastine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02905MIG. Most nations, for tariff and trade purposes, schedule levocabastine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, LEVOCABASTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Levocabastine hydrochloride bears US NLM identifiers UMLS ID C0244861 and NCI Concept Code C47582. SMILES: C[C@H]1[C@@](CCN(C1)[C@H]2CC[C@@](CC2)(C3CCC(CC3)F)C#N)(C(=O)O)C4CCCCC4.CL.